Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation.
Gonzalez-Vilchez F, Vazquez de Prada JA, Almenar L, Arizon Del Prado JM, Mirabet S, Diaz-Molina B, Delgado JF, Gomez-Bueno M, Paniagua MJ, Perez-Villa F, Roig E, Martínez-Dolz L, Brossa V, Lambert JL, Segovia J, Crespo-Leiro MG, Ruiz-Cano MJ.
Gonzalez-Vilchez F, et al. Among authors: roig e.
J Heart Lung Transplant. 2012 Mar;31(3):288-95. doi: 10.1016/j.healun.2011.10.011. Epub 2011 Dec 1.
J Heart Lung Transplant. 2012.
PMID: 22133787